Identification of a Leishmania infantum gene mediating resistance to ‘ and SbIII
- 1 October 2008
- journal article
- Published by Elsevier in International Journal for Parasitology
- Vol. 38 (12) , 1411-1423
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- A Proteomics Screen Implicates HSP83 and a Small Kinetoplastid Calpain-related Protein in Drug Resistance in Leishmania donovani Clinical Field Isolates by Modulating Drug-induced Programmed Cell DeathMolecular & Cellular Proteomics, 2007
- Oral miltefosine for the treatment of Indian visceral leishmaniasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 2006
- Combination of Suboptimal Doses of Inhibitors Targeting Different Domains of LtrMDR1 Efficiently Overcomes Resistance of Leishmania spp. to Miltefosine by Inhibiting Drug EffluxAntimicrobial Agents and Chemotherapy, 2006
- Oligoproline Effects on Polyglutamine Conformation and AggregationJournal of Molecular Biology, 2006
- Treatment of visceral leishmaniasisExpert Opinion on Pharmacotherapy, 2005
- Leishmania donovani Resistance to Miltefosine Involves a Defective Inward Translocation of the DrugAntimicrobial Agents and Chemotherapy, 2003
- Virulence ofLeishmania infantumIs Expressed as a Clonal and Dominant Phenotype in Experimental InfectionsInfection and Immunity, 2001
- Miltefosine, an Oral Agent, for the Treatment of Indian Visceral LeishmaniasisNew England Journal of Medicine, 1999
- Oral treatment of visceral leishmaniasis with miltefosinePathogens and Global Health, 1999
- An approach to functional complementation by introduction of large DNA fragments into Trypanosoma cruzi and Leishmania donovani using a cosmid shuttle vectorMolecular and Biochemical Parasitology, 1994